FDA advisers vote to recommend preterm birth drug Makena be removed from market

A US Food and Drug Administration advisory committee voted Wednesday that a drug approved more than a decade ago to reduce the risk of preterm birth should not be allowed to remain on the market after a larger study failed to show that it was effective. It's now up to FDA leaders to make a final decision about whether to remove the drug from the market.

from CNN.com - RSS Channel - Health https://ift.tt/WwQvlkc
via IFTTT